The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.
This entry was posted
on Thursday, September 11th, 2025 at 7:01 am and is filed under Business.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.